Consequences of the 340B Drug Pricing Program
N Engl J Med
.
2018 May 24;378(21):2053.
doi: 10.1056/NEJMc1802999.
Authors
Samuel L Ross
1
,
Benjamin D Li
2
Affiliations
1
Bon Secours Baltimore Health System, Baltimore, MD samuel_ross@bshsi.org
2
Case Western Reserve University, Cleveland, OH
PMID:
29792408
DOI:
10.1056/NEJMc1802999
No abstract available
Publication types
Letter
Comment
MeSH terms
Costs and Cost Analysis*
Drug Costs*
Humans